Correlation of BAL Cell Count and Pulmonary Function Tests in the Era of Antifibrotics: Data From the Belgium-Luxembourg Idiopathic Pulmonary Fibrosis Registry
Chest
.
2023 Feb;163(2):358-361.
doi: 10.1016/j.chest.2022.09.031.
Epub 2022 Sep 29.
Authors
Antoine Froidure
1
,
Benjamin Bondue
2
,
Caroline Dahlqvist
3
,
Julien Guiot
4
,
Natacha Gusbin
5
,
Gil Wirtz
6
,
Guy Joos
7
,
Didier Cataldo
4
,
Danielle Strens
8
,
Hans Slabbynck
9
,
Wim A Wuyts
8
Affiliations
1
Pulmonology Department, Cliniques universitaires Saint-Luc, Bruxelles, Belgium. Electronic address: antoine.froidure@saintluc.uclouvain.be.
2
Pulmonology Department, Hôpital Erasme, Bruxelles, Belgium.
3
Pulmonology Department, CHU-UCL Namur, Yvoir, Belgium.
4
Pulmonology Department, CHU Liège, Liège, Belgium.
5
Pulmonology Department, CHR Citadelle, Liège, Belgium.
6
Pulmonology Department, CHL, Luxembourg, Luxembourg.
7
Pulmonology Department, Ghent University Hospital, Gent, Belgium.
8
Pulmonology Department, UZ Leuven, Leuven, Belgium.
9
Pulmonology Department, ZNA Middelheim, Antwerpen, Belgium.
PMID:
36183786
DOI:
10.1016/j.chest.2022.09.031
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Belgium / epidemiology
Bronchoalveolar Lavage Fluid
Humans
Idiopathic Pulmonary Fibrosis* / drug therapy
Luxembourg
Registries
Respiratory Function Tests